Akili, Inc.
AKLI

$34.1 M
Marketcap
$0.43
Share price
Country
$0.00
Change (1 day)
$1.25
Year High
$0.19
Year Low

Akili, Inc., a digital medicine company, develops digital therapeutics for cognitive impairments. It provides EndeavorRx, a physician-prescribed video game-based treatment designed to directly target cognitive functioning. The company is based in Boston, Massachusetts.

marketcap

Earnings for Akili, Inc. (AKLI)

Earnings in 2023 (TTM): $-59,493,000

According to Akili, Inc.'s latest financial reports the company's current earnings (TTM) are $-59,493,000. The earnings displayed on this page is the company's Pretax Income.

Earnings history of Akili, Inc.

Annual Earnings

Year Income Before Tax Net Income
2023 $-59,493,000 $-59,493,000
2022 $-7,945,000 $-7,964,000
2021 $-61,348,000 $-61,830,000
2020 $-25,645,000 $-25,646,000
2019 $-20,621,000 $-20,634,000